Trump Slaps 100% Tariff on Imported Brand-Name Drugs
AP Photo/Mark Schiefelbein
Americans may soon face higher prices for certain medications after President Trump ordered a major new tariff on imported brand-name drugs. On Thursday, the administration announced a 100 percent tariff on many of these medicines, a move the White House says is intended to reduce the nation’s reliance on foreign-produced pharmaceuticals and their ingredients. Officials described the policy as a national security measure designed to strengthen domestic drug manufacturing.
The announcement came on the one-year anniversary of what the administration called “Liberation Day,” when President Trump first introduced broad tariffs on goods from nearly every country. On the same day as the drug tariff announcement, the administration also adjusted tariffs affecting industrial metals.
The policy does not apply equally to all pharmaceutical products. Drug companies that have entered into “Most Favored Nation” agreements with the administration are exempt, as are generic medications and drugs designated for rare diseases. Pharmaceutical firms that commit to building manufacturing facilities in the United States will face a lower tariff rate of 20 percent.
Different rates will also apply depending on where the medicines originate. Imports from the European Union, Japan, South Korea, Switzerland, and Liechtenstein will be subject to a 15 percent tariff. Medications from the United Kingdom will be handled under a separate trade agreement still being negotiated.
Administration officials say the goal is to make international buyers contribute more toward the cost of developing new treatments. They argue that American patients currently bear too much of the financial burden for research and development of future life-saving medicines.
However, pharmaceutical industry groups say the policy could have the opposite effect. Lobbyists for the industry warn that the tariffs may raise drug prices and discourage investment in U.S. production. They also point out that most medicines used in the United States are already manufactured domestically or imported from allied countries.
About Post Author
